Skip to main content

Not investment advice.Read full disclaimer

Healthcare · Biotechnology

52W Range

22thpctl

Volume

0.07×avg

Market Cap

4.97MUSD

P/E Ratio

-0.9TTM

Div Yield

-ann

Continue with finqOS

Explore Addex Therapeutics Ltd's financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

Addex Therapeutics Ltd

ADXNNASDAQ Capital Market·USD·Closed

Addex Therapeutics Ltd

ADXNNASDAQ·USD·Closed

$6.90

+17.75%

$6.90

+$1.04 (17.75%)

52W Range

22thpctl

Volume

0.07×avg

Mkt Cap

4.97MUSD

P/E

-0.9TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

ADXN: Addex Therapeutics Ltd Financial Statements & Revenue | finqOS